Ultratrace Iobenguane I-131

iobenguane I-131 · Molecular Insight Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Ultratrace Iobenguane I-131, covering 2011-10-12 to 2019-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

See pricing